Accurate population-based information on cancer patient survival is indispensable
for effective cancer control, and cancer registries have the essential task of collecting
that information.
1
While clinicians need survival from clinical series to evaluate the efficacy of their
treatments, only population-based survival comparisons can provide information on
the effectiveness of healthcare systems.
2
,
3
Population-based cancer registration is also necessary for monitoring cancer incidence
and for estimating cancer prevalence (the proportion of people living with a diagnosis
of cancer) which are required for healthcare planning and resource allocation. Cancer
mortality also provides important information for cancer control but, as discussed
subsequently, it is not sufficient on its own.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Responding to the challenge of cancer in Europe.Institute of Public Health of the Republic of Slovenia, Ljubljana2008
- Cancer control in Europe: a proposed set of European cancer health indicators.Eur J Public Health. 2003; 13: 116-118
- Strategies for cancer control in Italy.Tumori. 2007; 93: 329-336
Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J. Survival of cancer patients in Europe.The EUROCARE study. IARC Scientific Publications no. 132. Lyon: IARC Press; 1995.
Berrino F, Capocaccia R, Estève J, et al. Survival of cancer patients in Europe: the EUROCARE -2 study. IARC Scientific Publications no. 151. Lyon: IARC Press; 1999.
- Survival of adult cancer patients in Europe diagnosed from 1978–1989: the EUROCARE II Study.Eur J Cancer. 1998; 34: 2137-2277
- Childhood cancer survival in Europe 1978–1992: the EUROCARE Study.Eur J Cancer. 2001; 37: 671-816
- Childhood cancer survival in Europe: an overview.Eur J Cancer. 2001; 37: 810-816
- Survival of cancer patients in Europe: the EUROCARE-3 study.Ann Oncol. 2003; 14: v1-v155
- Geographical comparison of cancer survival in European children (1988–1997): report from the automated childhood cancer information system project.Eur J Cancer. 2006; 42: 1972-1980
- Cancer survival increases in Europe, but international differences remain wide.Eur J Cancer. 2001; 37: 1659-1667
- Survival trends in European cancer patients diagnosed from 1988 to 1999.Eur J Cancer. 2009; 45: 1042-1066
- Organizing a comprehensive framework for cancer control.in: Coleman M. Alexe D.M. Albreht T. Mckee M. Responding to the challenge of cancer in Europe. Institute of Public Health of the Republic of Slovenia, Ljubljana2008: 113-133
- Current cancer profiles of the Italian regions.Tumori. 2007; 93: 329-408
- Variation in survival after diagnosis of breast cancer in Switzerland.Ann Oncol. 2005; 16: 1882-1888
- Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001.Br J Cancer. 2004; 90: 1367-1373
- Cancer survival in England and Wales at the end of the 20th century.Br J Cancer. 2008; 99: S2-S10
- Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?-a population-based study.Eur J Cancer. 2004; 40: 1233-1243
- Long-term survival expectations of cancer patients in Europe in 2000–2002.Eur J Cancer. 2009; 45: 1028-1041
- Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data.Lancet Oncol. 2007; 8: 784-796
- The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis.Eur J Cancer. 2009; 45: 909-930
- The cure of cancer: A European perspective.Eur J Cancer. 2009; 45: 1067-1079
- Multiple tumours in survival estimates.Eur J Cancer. 2009; 45: 1080-1094
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary.Eur J Cancer. 2009; 95: 931-991
- Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study.Lancet Oncol. 2007; 8: 773-783
- Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.Eur J Cancer. 2007; 43: 909-913
Organization for economic Co-operation and development (OECD). OECD Health Data 2004. 1st ed. Paris: OECD; 2004.
- EUROCARE-2: relevance for assessment of quality of cancer services?.Lancet. 2000; 355: 427-428
- Cancer survival statistics should be viewed with caution.Lancet Oncol. 2007; 8: 1050-1052
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.Eur J Cancer. 2008; 44: 1345-1389
- The impact of coding process on observed cancer mortality trends in Switzerland.Eur J Cancer Prev. 2004; 13: 77-81
- The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.N Engl J Med. 1985; 312: 1604-1608
- Neoplasia in childhood-25 years of progress.Ann Oncol. 1995; 6: 3-8
- Childhood cancer survival trends in Europe: a EUROCARE Working Group study.J Clin Oncol. 2005; 23: 3742-3751
- Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997–2001).Br J Cancer. 2006; 95: 1265-1268
- Drugs for cancer.in: Coleman M. Alexe D.M. Albreht T. Mckee M. Responding to the challenge of cancer in Europe. Institute of Public Health of the Republic of Slovenia, Ljubljana2008: 93-112
- Stage-specific survival of epithelial cancers in North-Holland /Flevoland, The Netherlands.Eur J Cancer. 2005; 41: 2321-2330
- Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990–2006 in the southeastern Netherlands.Eur J Cancer. 2008; 44: 1846-1854
- Quality of treatment in routine care in a population sample of rectal cancer patients.Acta Oncol. 2005; 44: 65-74
- The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.J Surg Oncol. 2007; 95: 447-454
- Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis.Int J Cancer. 2007; 120: 1986-1992
- Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients.Eur J Surg Oncol. 2005; 31: 512-520
- Relative survival of Danish cancer patients diagnosed 1981 to 1997 and followed to 2001. A status report.Ugeskr Laeger. 2002; 164: 2855-2864
- Trends in colorectal cancer survival in northern Denmark: 1985–2004.Colorectal Dis. 2007; 9: 210-217
- Redesigning cancer care.Br Med J. 2002; 324: 164-166
- Breast carcinoma survival in Europe and the United States.Cancer. 2004; 100: 715-722
- Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe.Int J Cancer. 2003; 106: 416-422
- Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study.Gut. 2000; 47: 533-538
- Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.Biometrics. 2008; 64: 10-19
- Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994–2003: summary of findings.Eur J Cancer. 2008; 44: 2074-2085
Article info
Publication history
Published online: February 17, 2009
Accepted:
January 9,
2009
Received in revised form:
January 5,
2009
Received:
December 3,
2008
Identification
Copyright
© 2009 Elsevier Ltd. Published by Elsevier Inc. All rights reserved.
